2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Cited by (1,000)

Items 101–200 of 1,000

1. The dedicated “Lp(a) clinic”: A concept whose time has arrived?
   Sotirios Tsimikas, Erik S.G. Stroes · 2020 · Atherosclerosis
2. Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome
   Xiaomin Hu, Hanyu Li, Xinyue Zhao, Ruilin Zhou, Honghong Liu, Yueshen Sun, Yue Fan, Yanan Shi, Shanshan Qiao, Shuang‐Jiang Liu et al. · 2021 · Theranostics
3. Dyslipidemia Management in Adults With Diabetes
   Julieta Lazarte, Robert Alexander Hegele · 2019 · Canadian Journal of Diabetes
4. Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long‐Term Follow‐up Study on Real‐World Patients Receiving Percutaneous Coronary Intervention
   Hui‐Hui Liu, Ye‐Xuan Cao, Jing‐Lu Jin, Hui‐Wen Zhang, Qi Hua, Yanfang Li, Yuan‐Lin Guo, Cheng‐Gang Zhu, Na‐Qiong Wu, Rui‐Xia Xu et al. · 2020 · Journal of the American Heart Association
5. Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
   Andreja Rehberger Likozar, Mark Zavrtanik, Miran Šebeštjen · 2020 · Annals of Medicine
6. Diabetes Canada 2018 clinical practice guidelines: Key messages for family physicians caring for patients living with type 2 diabetes.
   Noah Michael Ivers, Maggie Jiang, Javed Alloo, Alexander G. Singer, Daniel Ngui, Carolyn Gall Casey, Catherine H. Y. Yu · 2019 · Europe PMC (PubMed Central)
7. Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review
   Merćep, Iveta, Friščić, Nikolina, Strikić, Dominik, Reiner, Željko · 2022 · Cardiovascular Therapeutics
8. Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
   Nazanin Aghel, Diego Delgado, Jeffrey Howard Lipton · 2017 · Vascular Health and Risk Management
9. Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
   Don P. Wilson, Terry A. Jacobson, Peter H. Jones, Marlys L. Koschinsky, Catherine J. McNeal, Børge Grønne Nordestgaard, Carl E. Orringer · 2022 · Journal of clinical lipidology
10. Cardiovascular/stroke risk predictive calculators: a comparison between statistical and machine learning models
    Ankush D. Jamthikar, Deep Gupta, Luca Saba, Narendra Nath Khanna, Tadashi Araki, Klaudija Višković, Sophie I. Mavrogeni, John R. Laird, Gyan Pareek, Martin M. Miner et al. · 2020 · Cardiovascular Diagnosis and Therapy
11. Lipoprotein(a): Knowns, unknowns and uncertainties
    Massimiliano Ruscica, Cesare Riccardo Sirtori, Alberto Corsini, Gerald Francis Watts, Amirhossein Sahebkar · 2021 · Pharmacological Research
12. Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies
    Francis Feldman, Mireille Koudoufio, Yves Desjardins, Schohraya Spahis, EDGARD E. DELVIN, Emile H. Levy · 2021 · Nutrients
13. The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes
    Stahel, Priska, Xiao, Changting, Hegele, Robert A., Lewis, Gary F. · 2018 · Canadian Journal of Cardiology
14. Relation of Vegetarian Dietary Patterns With Major Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies
    Andrea J. Glenn, Effie Viguiliouk, Maxine Seider, Beatrice A. Boucher, Tauseef Ahmad Khan, Sonia Blanco Mejía, David J.A. Jenkins, Hana Kahleová, Dario Rahelić, Jordi Salas‐Salvadó et al. · 2019 · Frontiers in Nutrition
15. Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
    Georgina Torrandell‐Haro, Gregory L. Branigan, Francesca Vitali, Nophar Geifman, Julie Zissimopoulos, Roberta Dı́az Brinton · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
16. Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
    Zdzisław Kochan, N. Szupryczyńska, Sylwia Małgorzewicz, Joanna Karbowska · 2021 · Nutrients
17. Perspective on the health effects of unsaturated fatty acids and commonly consumed plant oils high in unsaturated fat
    Kristina S. Petersen, Kevin Carl Maki, Philip C. Calder, Martha Ann Belury, Mark J. Messina, Carol F. Kirkpatrick, William Stephen Harris · 2024 · British Journal Of Nutrition
18. Multiclass machine learning vs. conventional calculators for stroke/CVD risk assessment using carotid plaque predictors with coronary angiography scores as gold standard: a 500 participants study
    Ankush D. Jamthikar, Deep Gupta, Laura E. Mantella, Luca Saba, John R. Laird, Amer M. Johri, Jasjit S. Suri · 2020 · International journal of cardiac imaging
19. Are fatty nuts a weighty concern? A systematic review and meta‐analysis and dose–response meta‐regression of prospective cohorts and randomized controlled trials
    Stephanie K. Nishi, Effie Viguiliouk, Sonia Blanco Mejía, Cyril W.C. Kendall, Richard Paul Bazinet, Anthony J. Hanley, Elena M. Comelli, Jordi Salas‐Salvadó, David J.A. Jenkins, John L. Sievenpiper · 2021 · Obesity Reviews
20. High lipoprotein(a): Actionable strategies for risk assessment and mitigation
    Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, Wess Boatwright, Christie Mitchell Ballantyne · 2024 · American Journal of Preventive Cardiology
21. Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice
    Diana De Oliveira-Gomes, Parag H. Joshi, Eric David Peterson, Anand K. Rohatgi, Amit Khera, Ann Marie Návar · 2024 · Circulation
22. Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies
    Peter Paul Toth, Olivier S Descamps, Jacques J. Genest, Naveed A. Sattar, David Preiss, Ricardo E. Dent, C. Stephen Djedjos, Yuna Wu, Michelle L. Geller, Magdalena Uhart et al. · 2017 · Circulation
23. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat
    Martin Bødtker Mortensen, Børge Grønne Nordestgaard · 2019 · JAMA Cardiology
24. Association of nonfasting vs fasting lipid levels with risk of major coronary events in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm
    Mora, Samia, Chang, C. Lan, Moorthy, M. Vinayaga, Sever, Peter S. · 2019 · JAMA Internal Medicine
25. Sex disparities in cardiovascular outcome trials of populations with diabetes: a systematic review and meta-analysis
    Clemens, Kristin K., Woodward, Mark, Neal, Bruce, Zinman, Bernard · 2020 · Diabetes Care
26. Relationship Between a Plant‐Based Dietary Portfolio and Risk of Cardiovascular Disease: Findings From the Women's Health Initiative Prospective Cohort Study
    Andrea J. Glenn, Kenneth Ka-Hei Lo, David J.A. Jenkins, Beatrice A. Boucher, Anthony J. Hanley, Cyril W.C. Kendall, JoAnn Elisabeth Manson, Mara Z. Vitolins, Linda Snetselaar, Simin Liu et al. · 2021 · Journal of the American Heart Association
27. Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol
    Su, Xin, Kong, Yi, Peng, Daoquan · 2019 · Lipids in Health and Disease
28. Normal-weight central obesity: Unique hazard of the toxic waist.
    N. John Bosomworth · 2019 · PubMed Central
29. Cardiovascular Protection in People With Diabetes
    James A. Stone, Robyn L. Houlden, Peter Lin, Jacob Allen Udell, Subodh Verma · 2018 · Canadian Journal of Diabetes
30. Dyslipidemia
    Mancini, G.B. John, Hegele, Robert A., Leiter, Lawrence A. · 2018 · Canadian Journal of Diabetes
31. Global Trends in the Epidemiology and Management of Dyslipidemia
    Tianxiao Liu, Dong Zhao, Yue Qi · 2022 · Journal of Clinical Medicine
32. Clinical Decision Support Tools in the Electronic Medical Record
    Mackenzie Ryann Alexiuk, Heba Elgubtan, Navdeep Tangri · 2023 · Kidney International Reports
33. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population
    Martin Bødtker Mortensen, Børge Grønne Nordestgaard · 2018 · Annals of Internal Medicine
34. The economic burden of not meeting food recommendations in Canada: The cost of doing nothing
    Jessica R. L. Lieffers, John Paul Ekwaru, Arto E. Ohinmaa, Paul J. Veugelers · 2018 · PLoS ONE
35. Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
    Michel R. Langlois, Allan D. Sniderman · 2020 · Current Cardiology Reports
36. COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type
    James R. Hilser, Neal J. Spencer, Kimia Moeeni Afshari, Frank D. Gilliland, Howard Hu, Arjun Deb, Aldons Jake Lusis, W.H. Wilson Tang, Jaana Hartiala, Stanley L. Hazen et al. · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
37. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies
    Harpreet Singh Bhatia, Michael J. Wilkinson · 2022 · Journal of Clinical Medicine
38. Enhanced long-term dietary change and adherence in a nutrigenomics-guided lifestyle intervention compared to a population-based (GLB/DPP) lifestyle intervention for weight management: Results from the NOW randomised controlled trial
    Horne, Justine, Gilliland, Jason, O'Connor, Colleen, Seabrook, Jamie, Madill, Janet · 2020 · BMJ Nutrition, Prevention & Health
39. Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe
    Isabelle L. Ruel, Sumayah Aljenedil, Iman Sadri, Émilie de Varennes, Robert Alexander Hegele, Patrick Couture, Jean Bergeron, Éric Wanneh, Alexis Wilfrid Baass, Robert Dufour et al. · 2017 · Clinical Chemistry
40. Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort Equations
    Dennis T. Ko, Atul Sivaswamy, Maneesh K. Sud, Gynter Kotrri, Paymon Azizi, Maria Koh, Peter C. Austin, Douglas S. Lee, Idan Roifman, George Thanassoulis et al. · 2020 · Canadian Medical Association Journal
41. Comparison of Current International Guidelines for the Management of Dyslipidemia
    Sevda Aygün, Lale S Tokgözoğlu · 2022 · Journal of Clinical Medicine
42. Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
    Brandon Flaig, Rachel Garza, Bhavdeep Singh, Sevag Hamamah, Mihai Covașă · 2023 · Nutrients
43. Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk
    Annabelle Santos Volgman, Marlys L. Koschinsky, Anurag Mehta, Robert S. Rosenson · 2024 · Journal of the American Heart Association
44. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus
    Stephanie Keeling, Zainab Alabdurubalnabi, Antonio Aviña-Zubieta, Susan G. Barr, Louise Bergeron, Sasha Bernatsky, Josiane Bourré‐Tessier, Ann Elaine Clarke, Alexandra Baril-Dionne, Jan Peter Dutz et al. · 2018 · The Journal of Rheumatology
45. Combating Inflammation in Cardiovascular Disease
    A. Sethwala, Ian Y Goh, John V. Amerena · 2020 · Heart Lung and Circulation
46. Mechanisms of Atherosclerosis Induced by Postprandial Lipemia
    Yixi Zhao, Longtao Liu, Shengjie Yang, Guijian Liu, Limin Pan, Chun Gu, Yang Wang, Dan Xiao Li, Ran Zhao, Min Wu · 2021 · Frontiers in Cardiovascular Medicine
47. Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials
    Danielle Lee, Laura Chiavaroli, Sabrina Ayoub‐Charette, Tauseef Ahmad Khan, Andreea Zurbau, Fei Au‐Yeung, Annette Cheung, Qi Liu, Xinye Qi, Amna Ahmed et al. · 2022 · Nutrients
48. Artificial intelligence framework for predictive cardiovascular and stroke risk assessment models: A narrative review of integrated approaches using carotid ultrasound
    Ankush D. Jamthikar, Deep Gupta, Luca Saba, Narendra Nath Khanna, Klaudija Višković, Sophie I. Mavrogeni, John R. Laird, Naveed A. Sattar, Amer M. Johri, Gyan Pareek et al. · 2020 · Computers in Biology and Medicine
49. Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: a 2019 Expert Panel Statement, Main Text
    Kolovou, Genovefa D., Watts, Gerald F., Mikhailidis, Dimitri P., Pérez-Martínez, Pablo, Mora, Samia, Bilianou, Helen, Panotopoulos, George, Katsiki, Niki, Ooi, Teik C., Lopez-Miranda, José et al. · 2019 · Current Vascular Pharmacology
50. Lipid-regulating properties of butyric acid and 4-phenylbutyric acid: Molecular mechanisms and therapeutic applications
    Bo He, Régis F. Moreau · 2019 · Pharmacological Research
51. Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials
    Paraskevi Massara, Andreea Zurbau, Andrea J. Glenn, Laura Chiavaroli, Tauseef Ahmad Khan, Effie Viguiliouk, Sonia Blanco Mejía, Elena M. Comelli, Victoria Chen, Ursula Schwab et al. · 2022 · Diabetologia
52. The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer
    Harry Klimis, Jehonathan H. Pinthus, Nazanin Aghel, Emmanuelle Duceppe, Vincent Fradet, Ian Hay Brown, David Robert Siemens, Bobby Shayegan, Laurence H. Klotz, Patrick P W Luke et al. · 2023 · JACC CardioOncology
53. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines
    Sathiyakumar, Vasanth, Park, Jihwan, Quispe, Renato, Elshazly, Mohamed B., Michos, Erin D., Banach, Maciej, Toth, Peter P., Whelton, Seamus P., Blumenthal, Roger S., Jones, Steven R. et al. · 2018 · Circulation
54. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study
    Yebyo, Henock G., Aschmann, Hélène E., Puhan, Milo A. · 2019 · Annals of Internal Medicine
55. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update
    Sheldon W. Tobe, James A. Stone, Todd J. Anderson, Simon Bacon, ALICE Y.Y. CHENG, Stella Styliani Daskalopoulou, Justin Adrian Ezekowitz, Jean C. Grégoire, Gord J. Gubitz, Rahul Jain et al. · 2018 · Canadian Medical Association Journal
56. Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
    Daniel I. Swerdlow, David A. Rider, Arash Yavari, Marie Lindholm, G. Campion, Steven E. Nissen · 2021 · Cardiovascular Research
57. Potential of front face fluorescence spectroscopy and fluorescence imaging in discriminating adulterated extra-virgin olive oil with virgin olive oil
    Ken Abamba Omwange, Dimas Firmanda Al Riza, Yoshito Saito, Tetsuhito Suzuki, Yuichi Ogawa, Keiichiro Shiraga, Ferruccio Giametta, Naoshi Kondo · 2021 · Food Control
58. Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study
    Hansen, Malene Kærslund, Mortensen, Martin Bødtker, Warnakula Olesen, Kevin Kris, Thrane, Pernille Gro, Maeng, Michael · 2024 · The Lancet Regional Health - Europe
59. A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review
    Suri, Jasjit S., Bhagawati, Mrinalini, Paul, Sudip, Protogerou, Athanasios D., Sfikakis, Petros P., Kitas, George D., Khanna, Narendra N., Ruzsa, Zoltan, Sharma, Aditya M., Saxena, Sanjay et al. · 2022 · Diagnostics
60. Portfolio Diet Score and Risk of Cardiovascular Disease: Findings From 3 Prospective Cohort Studies
    Andrea J. Glenn, Marta Guasch‐Ferré, Vasanti Malik, Cyril W.C. Kendall, JoAnn Elisabeth Manson, Eric B. Rimm, Walter Churchill Willett, Qi Sun, David J.A. Jenkins, Frank B. Hu et al. · 2023 · Circulation
61. Advances in treatment of Dyslipidemia
    Dybiec, Jill, Baran, Wiktoria, Dąbek, Bartłomiej, Fularski, Piotr, Młynarska, Ewelina, Radzioch, Ewa, Rysz, Jacek, Franczyk, Beata · 2023 · International Journal of Molecular Sciences
62. Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives
    Panagiotis Theofilis, Aikaterini Vordoni, Maria Koukoulaki, Georgios Vlachopanos, Rigas Kalaitzidis · 2021 · American Journal of Nephrology
63. Non-traditional lipid parameters as potential predictors of carotid plaque vulnerability and stenosis in patients with acute ischemic stroke
    Zhao Zhao, Huanru Wang, Qian Hou, Youting Zhou, Yanchun Zhang · 2022 · Neurological Sciences
64. Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
    Federica Galimberti, Manuela Casula, Elena Olmastroni · 2023 · Pharmacological Research
65. Lupin-Derived Bioactive Peptides: Intestinal Transport, Bioavailability and Health Benefits
    Innocent Uzochukwu Okagu, Joseph Chinedum Ndefo, Emmanuel Chigozie Aham, Joy I. Obeme-Nmom, Precious Eseose Agboinghale, Rita Ngozi Aguchem, Regina Nwamaka Nechi, Carmen Lammi · 2021 · Nutrients
66. Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients Without Diabetes
    Kun Yang, Wenxian Liu · 2021 · Frontiers in Endocrinology
67. Rates of inappropriate laboratory test utilization in Ontario
    Nadine Chami, Janet E. Simons, Arthur Sweetman, Andrew Don-Wauchope · 2017 · Clinical Biochemistry
68. Association of the TG/HDL-C and Non-HDL-C/HDL-C Ratios with Chronic Kidney Disease in an Adult Chinese Population
    Jia Wen, Yi‐Yin Chen, Yun Huang, Yao Lu, Xing Liu, Hong‐Hao Zhou, Hong Yuan · 2017 · Kidney & Blood Pressure Research
69. Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease
    Juan Francisco Sánchez Muñoz-Torrero, Sergio Rico‐Martín, Lorenzo Ramón Álvarez, Eduardo Aguilar, José Nicolás Alcalá, Manuel Monréal · 2018 · Atherosclerosis
70. Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study
    Andrea J. Glenn, Pablo Hernández‐Alonso, Cyril W.C. Kendall, Miguel Ángel Martínez‐González, Dolores Corella, Montserrat Fitó, José Alfredo Martínez, Ángel M. Alonso‐Gómez, Julia Wärnberǵ, Jesús Vioqué et al. · 2021 · Clinical Nutrition
71. Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort
    Vine, Donna, Ghosh, Mahua, Wang, Ting, Bakal, Jeffrey · 2024 · CJC Open
72. Statin initiation and risk of incident kidney disease in patients with diabetes
    Shiyu Zhou, Licong Su, Ruqi Xu, Yanqin Li, Ruixuan Chen, Yue Cao, Peiyan Gao, Xiaodong Zhang, Fan Luo, Qi Gao et al. · 2023 · Canadian Medical Association Journal
73. Cholesterol-Lowering Agents
    Savvas Hadjiphilippou, Kausik Kumar Ray · 2019 · Circulation Research
74. 2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease
    Martin Bødtker Mortensen, Børge Grønne Nordestgaard · 2020 · European Heart Journal
75. Current Cardiovascular Risk Reports
    2013 · Current Cardiovascular Risk Reports
76. Potential impacts of climate-related decline of seafood harvest on nutritional status of coastal First Nations in British Columbia, Canada
    Lesya Marushka, Tiff‐Annie Kenny, Malek Batal, William W. L. Cheung, Karen Fediuk, Christopher De Weir Golden, Anne Katherine Salomon, Tonio Sadik, Lauren V. Weatherdon, Hing Man Chan · 2019 · PLoS ONE
77. Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging
    Ankush D. Jamthikar, Deep Gupta, Anudeep Puvvula, Amer M. Johri, Narendra Nath Khanna, Luca Saba, Sophie I. Mavrogeni, John R. Laird, Gyan Pareek, Martin M. Miner et al. · 2020 · Rheumatology International
78. Deep learning artificial intelligence framework for multiclass coronary artery disease prediction using combination of conventional risk factors, carotid ultrasound, and intraplaque neovascularization
    Amer M. Johri, Krishna Veer Singh, Laura E. Mantella, Luca Saba, Aditya Sharma, John R. Laird, Kumar Utkarsh, Inder M. Singh, Suneet Gupta, Manudeep S. Kalra et al. · 2022 · Computers in Biology and Medicine
79. High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management
    Hong Y. Choi, Anouar Hafiane, Adel Giaid Schwertani, Jacques J. Genest · 2016 · Canadian Journal of Cardiology
80. Awareness of cardiovascular disease associated risk factors among Saudis in Riyadh City
    Ahmed H. Mujamammi, Yousef M Alluhaymid, Mohammed G. Alshibani, Fawzan Y Alotaibi, KhalidM Alzahrani, Abdulmajeed Alotaibi, Ahmed A Almasabi, Essa Mohammed Sabi · 2020 · Journal of Family Medicine and Primary Care
81. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease
    Suurya Krishnan, Wan Cheng Tan, Raquel Farias, Shawn David Aaron, Andrea Benedetti, Kenneth R. Chapman, Paul Hernandez, François Maltais, Darcy D. Marciniuk, Denis E. O’Donnell et al. · 2023 · CHEST Journal
82. Identification and Management of Atherosclerotic Cardiovascular Disease Risk in South Asian Populations in the U.S.
    Anandita Agarwala, Priyanka Satish, Mahmoud Al Rifai, Anurag Mehta, Miguel Cainzos‐Achirica, Nilay S. Shah, Alka M. Kanaya, Garima V. Sharma, Dave L. Dixon, Roger Scott Blumenthal et al. · 2023 · JACC Advances
83. Development and validation of a cardiovascular disease risk-prediction model using population health surveys: the Cardiovascular Disease Population Risk Tool (CVDPoRT)
    Douglas G. Manuel, Meltem Tuna, Carol L. Bennett, Deirdre A. Hennessy, Laura C. Rosella, Claudia Sanmartin, Jack V. Tu, Richard Perez, Stacey Fisher, Monica Taljaard · 2018 · Canadian Medical Association Journal
84. Statins for Primary Prevention in Those Aged 70 Years and Older: A Critical Review of Recent Cholesterol Guidelines
    Chelsea E. Hawley, John Roefaro, Daniel E. Forman, Ariela R. Orkaby · 2019 · Drugs & Aging
85. Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial
    Junbo Ge, Fan Wei-hu, Jingmin Zhou, Haiming Shi, Fusui Ji, Yang Wu, Yulan Zhao, Jun Qian, Yuan‐Zhe Jin, Yingwu Liu et al. · 2020 · Chinese Medical Journal
86. Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors
    Kwok Leung Ong, Robyn L. McClelland, Matthew Allison, Mary Cushman, Parveen K. Garg, Michael Y. Tsai, K.-A. Rye, Fatiha Tabet · 2021 · Metabolism
87. Dietary Glycaemic Index Labelling: A Global Perspective
    Alan Winston Barclay, Livia S. A. Augustin, Furio Brighenti, Elizabeth Delport, Christiani Jeyakumar Henry, John L. Sievenpiper, Kathy Usic, Yang Yuexin, Andreea Zurbau, Thomas M. S. Wolever et al. · 2021 · Nutrients
88. Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update
    Rahul Jain, James A. Stone, Gina Agarwal, Jason G. Andrade, Simon Bacon, HARPREET SINGH BAJAJ, Brian Baker, Gemma Cheng, David A. Dannenbaum, Mark Gelfer et al. · 2022 · Canadian Medical Association Journal
89. 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure
    Donald E. Casey, Randal J. Thomas, Vivek Bhalla, Yvonne Y Commodore-Mensah, Paul A. Heidenreich, Dhaval Sanjeev Kolte, Paul Muntner, Sidney C. Smith, John A. Spertus, John R. Windle et al. · 2019 · Journal of the American College of Cardiology
90. Cardiovascular Risk in Individuals with Inflammatory Bowel Disease
    Robertha Biondi, Péricles Sidnei Salmazo, Silméia Garcia Zanati Bazan, João Carlos Hueb, Sérgio Alberto Rupp de Paiva, Lígia Yukie Sassaki · 2020 · Clinical and Experimental Gastroenterology
91. Nutritional Requirements of Lung Transplant Recipients: Challenges and Considerations
    Valérie Jomphe, Larry C. Lands, Geneviève Mailhot · 2018 · Nutrients
92. Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for Treatment of Dyslipidemia Based on Recent Guidelines
    Perry Wengrofsky, Justin Lee, Amgad N. Makaryus · 2019 · IntechOpen eBooks
93. Cumulative Meta‐Analysis of the Soy Effect Over Time
    David J.A. Jenkins, Sonia Blanco Mejía, Laura Chiavaroli, Effie Viguiliouk, Siying S. Li, Cyril W.C. Kendall, Vladmir Vuksan, John L. Sievenpiper · 2019 · Journal of the American Heart Association
94. Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment.
    Victoria Higgins, Khosrow Adeli · 2017 · PubMed Central
95. Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk
    Ciaran Navin Kohli-Lynch, Brandon Kyle Bellows, George Thanassoulis, Yiyi Zhang, Mark J. Pletcher, Eric Vittinghoff, Michael J. Pencina, Dhruv S. Kazi, Allan D. Sniderman, Andrew Edward Moran · 2019 · JAMA Cardiology
96. Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study
    Mehdi Shahriyari Afshar, Jian Rong, Yang Zhan, Hao Yu Chen, James C. Engert, Allan D. Sniderman, Martin G. Larson, Ramachandran Srini Vasan, George Thanassoulis · 2020 · Journal of the American Heart Association
97. More accurate LDL-C calculation: Externally validated, guideline endorsed
    Adam J. Brownstein, Seth Shay Martin · 2020 · Clinica Chimica Acta
98. Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy
    Richard H. Swartz, Noor Niyar N. Ladhani, Norine C. Foley, Kara A. Nerenberg, Simerpreet S. Bal, Jon F.R. Barrett, Cheryl Bushnell, Wee‐Shian Chan, Radha S. Chari, Dar D Dowlatshahi et al. · 2017 · International Journal of Stroke
99. Nuts and Cardiovascular Disease Outcomes: A Review of the Evidence and Future Directions
    Andrea J. Glenn, Dagfinn Aune, Heinz Freisling, Noushin Mohammadifard, Cyril W.C. Kendall, Jordi Salas‐Salvadó, David J.A. Jenkins, Frank B. Hu, John L. Sievenpiper · 2023 · Nutrients
100. Lipoprotein(a): Emerging insights and therapeutics
     Gurleen Kaur, Khaled Abdelrahman, Adam N. Berman, David W. Biery, Arthur Shiyovich, Daniel M. Huck, Michael Seth Garshick, Ron Blankstein, Brittany Weber · 2024 · American Journal of Preventive Cardiology